The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
本发明涉及使用
吡唑并
嘧啶化合物制备药物组合物,用于预防和/或治疗可以通过抑制Mnk1和/或Mnk2(Mnk2a或Mnk2b)激酶活性及/或其变体影响的疾病。